ASXL1 |
Q8IXJ9
|
ASXL transcriptional regulator 1
|
|
1.3E-14 |
0.482 |
0.808 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
BTK |
Q06187
|
Bruton tyrosine kinase
|
Kinase
|
1.00 |
0.464 |
0.808 |
CCL2 |
P13500
|
C-C motif chemokine ligand 2
|
Signaling
|
0.61 |
0.321 |
0.962 |
CD19 |
P15391
|
CD19 molecule
|
|
0.90 |
0.430 |
0.885 |
CD34 |
P28906
|
CD34 molecule
|
|
5.0E-06 |
0.368 |
0.808 |
CD40LG |
P29965
|
CD40 ligand
|
Signaling
|
0.72 |
0.414 |
0.846 |
CSF2 |
P04141
|
colony stimulating factor 2
|
Signaling
|
0.83 |
0.330 |
0.962 |
CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
CSF3R |
Q99062
|
colony stimulating factor 3 receptor
|
Signaling
|
1.5E-10 |
0.550 |
0.692 |
CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
CXCR4 |
P61073
|
C-X-C motif chemokine receptor 4
|
G-protein coupled receptor
|
1.8E-02 |
0.362 |
0.923 |
CYP2B6 |
P20813
|
cytochrome P450 family 2 subfamily B member 6
|
|
1.9E-10 |
0.428 |
0.846 |
DNAJC21 |
Q5F1R6
|
DnaJ heat shock protein family (Hsp40) member C21
|
|
2.1E-07 |
0.606 |
0.731 |
EFL1 |
Q7Z2Z2
|
elongation factor like GTPase 1
|
Enzyme
|
5.1E-08 |
0.638 |
0.577 |
ELANE |
P08246
|
elastase, neutrophil expressed
|
Enzyme
|
1.2E-03 |
0.447 |
0.846 |
FANCA |
O15360
|
FA complementation group A
|
|
1.6E-68 |
0.505 |
0.731 |
FANCD2 |
Q9BXW9
|
FA complementation group D2
|
|
1.1E-30 |
0.479 |
0.885 |
FANCG |
O15287
|
FA complementation group G
|
|
2.5E-14 |
0.556 |
0.769 |
FCGR3A |
P08637
|
Fc fragment of IgG receptor IIIa
|
Cell adhesion
|
3.7E-06 |
0.432 |
0.962 |
FCGR3B |
O75015
|
Fc fragment of IgG receptor IIIb
|
Cell adhesion
|
3.0E-07 |
0.452 |
0.962 |
GATA1 |
P15976
|
GATA binding protein 1
|
|
0.95 |
0.483 |
0.808 |
GATA2 |
P23769
|
GATA binding protein 2
|
|
0.98 |
0.496 |
0.654 |
GEM |
P55040
|
GTP binding protein overexpressed in skeletal muscle
|
|
1.2E-08 |
0.467 |
0.769 |